1270P - Pembrolizumab in advanced rare cancers

Autor:	Naing, A. 1, Meric-Bernstam, F. 1, Karp, D. 1, Rodon, J.A. 1, Piha-Paul, S.A. 1, Subbiah, V. 1, Hong, D.S. 1, Pant, S. 1, Fu, S. 1, Janku, F. 1, Yap, T.A. 1, Tsimberidou, A.M. 1, Dumbrava, E E Ileana 1, Colen, R.R. 2, Hess, K.R. 3, Campbell, M.T. 4, Tu, S.-M. 4, Jimenez, C. 5, Habra, M.A. 5, Varadhachary, G.R. 6
Zdroj:	In Annals of Oncology October 2019 30 Supplement 5:v516-v517
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu